Skip to main content
. 2014 Apr 8;3(4):909–918. doi: 10.1002/cam4.244

Figure 1.

Figure 1

Box plots show levels of WT1 IgG Ab titers in plasma samples in different groups of patients with ovarian tumors. No differences in WT1 IgG Ab titers are detected in plasma samples between patients with malignant, borderline, and benign ovarian tumors.